Krečak, I.; Pivac, L.; Lucijanić, M.; Skelin, M.
Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms. Biomedicines 2023, 11, 1301.
https://doi.org/10.3390/biomedicines11051301
AMA Style
Krečak I, Pivac L, Lucijanić M, Skelin M.
Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms. Biomedicines. 2023; 11(5):1301.
https://doi.org/10.3390/biomedicines11051301
Chicago/Turabian Style
Krečak, Ivan, Ljerka Pivac, Marko Lucijanić, and Marko Skelin.
2023. "Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms" Biomedicines 11, no. 5: 1301.
https://doi.org/10.3390/biomedicines11051301
APA Style
Krečak, I., Pivac, L., Lucijanić, M., & Skelin, M.
(2023). Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms. Biomedicines, 11(5), 1301.
https://doi.org/10.3390/biomedicines11051301